The investigators concluded that it is not feasible due to the lack of participation and difficulty in recruiting patients.

This is a pilot study to establish the feasibility of an eight-week yoga intervention and to estimate the effect size on QoL in female patients with ovarian, fallopian tube and primary peritoneal malignancies receiving chemotherapy for the treatment of primary or recurrent cancer.

The primary objective of this study was to determine the feasibility of implementing a yoga program among gynecologic cancer patients receiving chemotherapy. The investigators concluded that it is not feasible due to the lack of participation and difficulty in recruiting patients. Of 25 consented patients, 16 agreed to participate in the control arm, 9 agreed to participate in the Yoga classes. Three (3) of those 9 changed their minds and withdrew consent. Of the 6 remaining patients, only 3 attended at least 1 of the 8 classes.

Inclusion Criteria:

• Histologically confirmed diagnosis of epithelial ovarian/fallopian tube/primary peritoneal cancer
• Participant must be age 18 or older
• Participants must be 6 weeks post-surgery
• Participant must be currently receiving chemotherapy or beginning a regimen within the next four weeks
• Participant must be willing to attend the intervention sessions
• All subjects must have given signed, informed consent prior to registration in the study.

Exclusion Criteria:

• Participant has practiced yoga more than 4 times in the last year
• Participant has a surgical procedure scheduled during the 8 weeks that they would be part of the intervention
• Participant has an ECOG performance status less than or equal to two